With the deadline of the Biofrontera deal coming up,it seems to me to be alot of potential building. To name a few: The release of Ovenome or Statinome, according to DNAPrint prediction, should happen soon. The deal with Orchid needing mention by DNAPrint. Consumation of the deal itself. Perhaps a goverment deal for the Terorist DNAWitness package, or for unsolved cases. Use in the JonBonet case.
News early in Jan. would give the pps a spike, giving us a better loan rate. A Dutton report that reflects these things might sustain that.
When a capitor releases it's potential, it packs a wallop. JMHO.
News 
Market Data 
Discover 
AI
